<doc>
	<lectureno>1</lectureno>
	<course>dummy</course>
	<date>dummy</date>
	<headline>dummy</headline>
	<url>
		https://ocw.mit.edu/courses/6-s897-machine-learning-for-healthcare-spring-2019/2020812c6b3be9e2c27873595d1a9aed_MIT6_S897S19_lec1.pdf</url>
	<slides>
		<slide>
			<slideno>0</slideno>
			<text>


				Machine Learning for Healthcare
				HST.956, 6.S897
				Lecture 1: What makes healthcare unique ?
				Prof. David Sontag &amp; Pete Szolovits
				1</text>
			<slideno>1</slideno>
			<text>


				The Problem
				‚Ä¢Cost of health ca re expenditures in the US are
				over $3 trillion, and rising
				‚Ä¢Despite having som e of the best clinicians in
				the world, chronic conditions are
				‚ÄìOften diagnosed lat e
				‚ÄìOften inappropriately mana ged
				‚Ä¢Medical errors are pervasive
				2</text>
			<slideno>2</slideno>
			<text>


				Outline for today‚Äôs class
				1.Brief history of A I and ML in healthcare
				2.Why now?
				3.Exa
				mples of how ML will transform
				healthcare
				4.What is unique abo ut ML in healthcare ?
				5.Overview of cla ss syllabus
				3</text>
			<slideno>3</slideno>
			<text>


				USERIDescription
				of new case
				Advice &amp;
				Explanation=~User
				inter-
				faceEXPERT SYSTEM
				qp~ Inference Engine
				t
				qp_~ Knowledge [Base
				FIGURE 1-1 Major parts of an expert system. Arrows indicate
				information flow.I am ready
				** THIS IS A 26 YEAR OLD MALE PATIENT
				My understanding is:
				The age of the patient is 26
				The sex of the patient is male
				** FIVE DAYS AGO, HE HAD RESPIRATORY-TRACT SYMPTOMS
				What is his name?** JO
				My understanding is:
				The name of the patient is Jo
				Respiratory-tract is one of the symptoms that the patient had
				** A COUPLE OF DAYS BEFORE THE ADMISSION, HE HAD A MALAISE
				Please give me the date of admission
				** MARCH 12, 1979My understanding is:
				The patient was admitted at the hospital 3 days ago
				Malaise is one of the symptoms that the patient had 5 days ago
				FIGURE 33-1 Short sample dialogue. The physician‚Äôs inputs
				appear in capital letters after the double asterisks.1970‚Äôs: MYCIN expert system
				‚Ä¢ 1970‚Äôs (Stanford): MY CIN expert Dialogue interface system for identifying
				bacteria
				causing severe infections
				‚Ä¢ Proposed a go od therapy in
				~69% of cases. Better than
				infectious disease experts
				4
				¬© Addison-Wesley Publishing Company, Inc. This content is excluded from our Creative
				Commons license. For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>4</slideno>
			<text>2%*UQ93)WX#S^XW"# _2`aP^)7@F-:
				!2%*UQ9)YG;&lt;H$)@C)?&lt;//9A01K5Z3
				WX#S^XW"# _2`a0&lt;.8)P-F&lt;.6:
				^-C-1-;. -
				!L&lt;6K;@9&lt;9)C@1)&lt;;/-1;6:)7-F&lt;.&lt;; -
				C:0 E;-07@;&lt;6 F&lt;6A-/-9
				L&lt;9-69-9
				"O7E/@79
				C6/&lt;K0-
				.@0K5 .5-9/ 5&lt;K5
				E6&lt;; b2B 1*-?"?%/%90%#(@-5'/(*'/"0%&amp;+A
				&amp;+U)A&lt;;61O)F&lt;9-69-)H61&lt;6A:-9
				T(U+&amp;)A&lt;;61O)9O7E/@7)H61&lt;6A:-9) T&amp;(T+U)F&lt;1-./-F)-FK-9
				S:&lt;.&lt;/-F)C1@7)F@./@193
				:B(C'*9-&amp; D&lt;'"*9(-,(E-*F
				)'5(0-("54"&amp;#'9(%&amp;(!)(7(=&gt;(
				G;"&lt;'9%"&amp;(&amp;'0E-*F9H("CC*-I%@"0'( %&amp;,'*'&amp;#'J
				1*-?/'@9A 2$ B:&lt;;&lt;.&lt;6;9)-;/-1-F)9O7E/@79) ()!$)**+
				R$ L&lt;CC&lt;.0:/)/@)76&lt;;/6&lt;;()F&lt;CC&lt;.0:/)/@)K-;-16:&lt;f -
				5
				cP&lt;::-1)-/)6:$()d*'() "5M- -/)6:$()d%2e </text>
			<slideno>5</slideno>
			<text>


				1980‚Äôs: automating medical discovery
				Discovers that prednisone
				elevates cholesterol
				(Annals of Internal Medicine, ‚Äò86)
				[Robert Blum, ‚ÄúDiscovery, Confirmation and Incorporation of Causal Relationships
				from a Large Time -Oriented Clinical Data Base: The RX Project‚Äù. Dept. of Computer
				Science, Stanford. 1981]
				Diagram ¬© Robert Blum . All rights reserved. This content is excluded from our
				Creative Commons license. For more information, see
				https://ocw.mit.edu/help/faq-fair-use/
				6</text>
			<slideno>6</slideno>
			<text>


				FIGURE 2. A multilayer perceptron. This is a two-layer percep-
				tron with four inputs, four hidden units, and one output unit.1990‚Äôs: neural
				networks in medicine
				‚Ä¢Neural networks with
				cl
				inical data took off in
				1990, with 88 new studies
				that year
				‚Ä¢Small number of f eatures
				(inputs)
				‚Ä¢Data often collected by
				ch
				art review
				Problems: 1. Did not fit well into clinical workflow
				2.Hard to get en ough training data
				3.Poor generalization to n ew places
				[Penny &amp; Frost,Neural Networks in Clinical Medicine. Med Decis Making, 1996]
				7
				¬© Society for Medical Decision Making. All rights reserved. This content is excluded
				from our Creative Commons license.
				For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>7</slideno>
			<text>


				Outline for today‚Äôs class
				1.Brief history of A I and ML in healthcare
				2.Why now?
				3.Exa
				mples of how ML will transform
				healthcare
				4.What is unique abo ut ML in healthcare ?
				5.Overview of cla ss syllabus
				8</text>
			<slideno>8</slideno>
			<text>


				71.9%85.2%*9496.9%*96%
				Certied EHR
				Basic EHR00000The Opportunity :
				Adoption of Electronic Health Records
				(EHR) has increased 9x in US since 2008
				%*
				9.4% 12.2% 15.6% 27.6%* 44.4%* 59.4%* 75.5%* 83.8%*
				Percentage
				of hospitals
				in the US
				2008 2009 2010 2011 2012 2013 2014 2015
				Courtesy of Health and Human Services. Image is in the public domain.
				[Henry et al., ONC Data Brief, May 2016]
				9</text>
			<slideno>9</slideno>
			<text>

				10,61K-)F6/69-/9
				,6A@16/@1O) C@1)
				B@7E0/6/&lt;@;6:)
				?5O9&lt;@:@KO
				L-_&lt;F-;/&lt;C&lt;-F)
				5-6:/5)F6/6)C1@7)
				[TUm).1&lt;/&lt;.6:).61 -)
				E6/&lt;-;/9
				L-7@K16E5&lt;.9 ()
				H&lt;/6:)9&lt;K;9()
				:6A@16/@1O)/-9/9() 7-F&lt;.6/&lt;@;9() ;@/-9() n
				¬© Lab for Computational Physiology. All rights reserved. This content is excluded
				from our Creative Commons license.
				For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>10</slideno>
			<text>


				Large datasets
				President Obama‚Äôs initiative to create a 1 million
				person research cohort Core data set:
				‚Ä¢ Baseline health ex am
				‚Ä¢ Clinical data de rived
				from electronic health
				records (EHRs )
				‚Ä¢ Healthcare cla ims
				‚Ä¢ Laboratory dat a
				[Precision Medicine Initiative (PMI) working Group Report, Sept. 17 2015]
				11</text>
			<slideno>11</slideno>
			<text>


				L&lt;H-19&lt;/O)@C)F&lt;K&lt;/6:)5-6:/5)F6/6
				genomics lab tests proteomics
				social media
				phone
				imaging
				vital signs
				devices
				/mages are h^ 'overnment wor≈¨. /mages are in the public domain.
				12</text>
			<slideno>12</slideno>
			<text>"/6;F61F&lt;f6/&lt;@;
				! L&lt;6K;@9&lt;9).@F-93)WBL _%)6;F
				WBL_2U)YW;/-1;6/&lt;@;6:
				B:699&lt;C&lt;.6/&lt;@;)@C) L&lt;9-69-9Z
				n
				n n
				5//E93``-; $M&lt;8&lt;E- F&lt;6$@1K`M&lt;8&lt;`,&lt;9/p@CpWBL_% p.@F-9
				5//E93``A: @K$.01-7F$.@7`/5-_7@ 9/_A&lt;f611-_&lt;.F_2U_.@F -9_&lt;;C@K16 E5&lt;.`
				13</text>
			<slideno>13</slideno>
			<text>
				"/6;F61F&lt;f6/&lt;@;
				! L&lt;6K;@9&lt;9).@F-93)WBL _%)6;F
				WBL_2U)YW;/-1;6/&lt;@;6:
				B:699&lt;C&lt;.6/&lt;@;)@C) L&lt;9-69-9Z
				! ,6A@16/@1O)/-9/93),NWXB
				.@F-9
				! ?56176.O3)X6/&lt;@;6:)L10K
				B@F-9)YXLB9Z
				! G;&lt;C&lt;-F) P-F&lt;.6:),6;K06K -
				"O9/-7)YGP,"Z3)7&lt;::&lt;@;9)@C7-F&lt;.6:).@;.-E/9
				¬© -O*/C. All rights reserved. This content is excluded
				from our Creative Commons license. For more
				information, see https://ocw.mit .edu/help/faq-fair-use/
				¬© Oplinc. All rights reserved. This content is excluded from our Creative Commons
				license. For more information, see https://ocw.mit.edu/help/faq-fair-use/
				14</text>
			<slideno>14</slideno>
			<text>"/6;F61F&lt;f6/&lt;@;
				/mage is in the public domain.
				15</text>
			<slideno>15</slideno>
			<text> Standardization
				OMOP
				Common Data Model v5.0
				Image is in the public domain.
				16</text>
			<slideno>16</slideno>
			<text>
				]1-68/51@0K59)&lt;;)76.5&lt;;-):-61;&lt;;K
				$%&amp;'!"#(
				! ]&lt;K)F6/6
				! b:K@1&lt;/57&lt;.)6FH6;.-9
				! NE-;_9@01.-)9@C/M61-
				¬© &amp;co nomist and 4tanford 7ision -aC. All rights reserved. This content is
				excluded from our Creative Commons license. For more information,
				see https://ocw .mit.edu/help/faq-fair-use/
				17</text>
			<slideno>17</slideno>
			<text>


				Breakthroughs in machine learning
				‚Ä¢ Major advances in ML &amp; AI
				‚Äì Learning with hi gh-dimensional features (e.g., l1-
				regularization)
				‚Äì Semi -supervised an d unsupervised learning
				‚Äì Modern deep le arning techniques (e.g. convnets ,
				variants of SGD)
				‚Ä¢ Democratization of m achine learning
				‚Äì High quality op en-source software, such as
				Python‚Äôs scikit -learn, TensorFlow , Torch, Theano
				18</text>
			<slideno>18</slideno>
			<text>19¬© Rock Health. All rights reserved. This content is excluded from our Creative
				Commons license.
				For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>19</slideno>
			<text>20¬© C# *nformation 4ervices. All rights reserved. This content is excluded from
				our Creative Commons license. For more information, see
				https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>20</slideno>
			<text>


				Industry interest in ML &amp; healthcare
				‚Ä¢ Major acquisitions to get big data for ML:
				‚Äì Merge ($1 billion p urchase by IBM, 2015)
				medical imaging
				‚Äì Tr
				uven Health An alytics ($2.6 billion purchase by
				IBM, 2016 )
				health insurance cl aims
				‚Äì Flatiron Health ($ 1.9 billion purchase by Roche,
				2018)
				electronic health rec ords (oncology)
				21</text>
			<slideno>21</slideno>
			<text>


				Outline for today‚Äôs class
				1. Brief history of AI and ML in healthcare
				2. Why now?
				3.
				Examples of ho w ML will transform
				healthcare
				4. What is unique ab out ML in healthcare ?
				5. Overview of cl ass syllabus
				22</text>
			<slideno>22</slideno>
			<text>P,)M&lt;::)/16;9C@17)-H-1O)69E-./)@C)5-6:/5.61 -
				#5-)9/68-5@:F-193
				¬™TPVSDFVOLOPXO"MMSJHIUTSFTFSWFE5IJTDPOUFOUJTFYDMVEFEGSPNPVS$SFBUJWF$PNNPOTMJDFOTF'PSNPSFJOGPSNBUJPO
				
				TFFIUUQTPDXNJUFEVIFMQGBRGBJSVTF
				23</text>
			<slideno>23</slideno>
			<text>


				24Emergency Department:
				‚Ä¢ Limited resources
				‚Ä¢ Time sensitive
				‚Ä¢ Critical decisions
				Courtesy of the US Navy. Image is in the public domain. </text>
			<slideno>24</slideno>
			<text>456/)M&lt;::)/5-)S^)@C)/5-)C0/01-)A-):&lt;8-&gt;
				]-5&lt;;F_/5-_9.-;-9)1-69@;&lt;;K)6A@0/)/5-)E6/&lt;-;/Q9 )
				.@;F&lt;/&lt;@;9)Y.011-;/)6;F)C0/01-Z
				C:0 E;-07@;&lt;6 F&lt;6A-/-9 ! ]-//-1)/1&lt;6K -
				! l69/-1) F&lt;6K;@9&lt;9
				! S61:O)F-/-./&lt;@;)@C
				6FH-19-)-H-;/9
				! ?1-H-;/)7-F&lt;.6: -11@19
				b0/@76/&lt;.6::O)-D/16./-F)C1@7)
				-:-./1@;&lt;.)5-6:/5)1-.@1F
				L&lt;9-69-9
				"O7E/@79
				C6/&lt;K0- .5-9/
				E6&lt;; .@0K5 5&lt;K5
				b2B
				L1&lt;H-9
				E6&lt;;
				b2B
				25</text>
			<slideno>25</slideno>
			<text>
				456/)M&lt;::)/5-)S^)@C)/5-)C0/01-)A-):&lt;8-&gt;
				?1@E6K6/&lt;;K)A-9/)E16./&lt;.-9 )
				26
				¬© source unLnown. All rights reserved. This content is excluded from our Creative
				Commons license. For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>26</slideno>
			<text> 456/)M&lt;::)/5-)S^)@C)/5-)C0/01-)A-):&lt;8-&gt;
				¬© source unLnown. All rights reserved. This content is excluded from our Creative
				Commons license. For more information, see https://ocw.mit.edu/help/faq-fair-use/
				b;/&lt;.&lt;E6/&lt;;K)/5-).:&lt;;&lt;.&lt;6;9Q
				;--F9
				27</text>
			<slideno>27</slideno>
			<text> 456/)M&lt;::)/5-)S^)@C)/5-)C0/01-)A-):&lt;8-&gt;
				^-F0.&lt;;K)/5-);--F)C@1)9E-.&lt;6:&lt;9/).@;90:/9
				Output
				Pneumonia Positive (85%) Input
				Chest X-Ray Image
				CheXNet
				121-layer CNN
				b115O/57&lt;6&gt;
				l&lt;K01-) 9@01.-93) ^6iE01861 -/)6:$()61h&lt;H32+22$U&amp;RR&amp;) Q2+
				^6iE01861 -/)6:$()61h&lt;H32+U+$U2*J'()q2+ ¬© 3aKpurLar et al. All rights reserved.
				This content is excluded from our
				Creative Commons license. For more information, see
				https://ocw.mit.edu/help/faq-fair-use/
				28</text>
			<slideno>28</slideno>
			<text> 456/)M&lt;::)/5-)S^)@C)/5-)C0/01-)A-):&lt;8-&gt;
				b0/@76/-F)F@.07-;/6/&lt;@;)6;F)A&lt;::&lt;;K
				#1&lt;6K-);@/-
				?1-F&lt;./-F)
				.5&lt;-C)
				.@7E:6&lt;;/9 B@;/-D/06:)
				60/@_
				.@7E:-/-
				29
				¬© source unLnown. All rights reserved. This content is excluded from our Creative
				Commons license. For more information, see https://ocw.mit.edu/help/faq-fair-use/ </text>
			<slideno>29</slideno>
			<text>P,)M&lt;::)/16;9C@17)-H-1O)69E-./)@C)5-6:/5.61 -
				#5-)9/68-5@:F-193
				¬™TPVSDFVOLOPXO"MMSJHIUTSFTFSWFE5IJTDPOUFOUJTFYDMVEFEGSPNPVS$SFBUJWF$PNNPOTMJDFOTF'PSNPSFJOGPSNBUJPO
				
				TFFIUUQTPDXNJUFEVIFMQGBRGBJSVTF
				30</text>
			<slideno>30</slideno>
			<text>456/)&lt;9)/5-)C0/01-)@C)5@M)M-)/1-6/)
				.51@;&lt;.)F&lt;9-69-&gt;
				! ?1-F&lt;./&lt;;K)6)E6/&lt;-;/Q9)C0/01-)F&lt;9-69-)E1@K1-99 &lt;@;
				R%@'
				Disease burden
				#&lt;7-Undiagnosed
				condition
				Courtesy of the CDC. Image is in the public domain.
				l&lt;K01-).1-F&lt;/3)5//E93``MMM$.F.$K@H`8 &lt;F;-OF&lt;9-69-`E1-H-;/&lt;@;_1
				&lt;98$5/7:
				31</text>
			<slideno>31</slideno>
			<text>

				456/)&lt;9)/5-)C0/01-)@C)5@M)M-)/1-6/)
				.51@;&lt;.)F&lt;9-69-&gt;
				! ?1-F&lt;./&lt;;K)6)E6/&lt;-;/Q9)C0/01-)F&lt;9-69-)E1@K1-99 &lt;@;
				! ?1-.&lt;9&lt;@;)7-F&lt;.&lt;; -
				S$--9%&amp;+(,%*90(/%&amp;'(0$'*"C&lt;(%&amp;(@Q/0%C/'(@&lt;'/-@"
				=J TU5A .61C&lt;:f@7&lt;A _:-;6:&lt;F@7&lt;F- _F-D67-/569@;- ();J(VU5A A@1/-f@7&lt;A
				_:-;6:&lt;F@7&lt;F- _F-D67-/569@;-
				Progression on KRd
				Treatment A
				Treatment B Patient w.
				condition X Response to treatment A
				Response to treatment B Diagnosis and first -line treatment
				Progression on VRd
				#&lt;7-
				32</text>
			<slideno>32</slideno>
			<text>


				What is the future of how we treat
				chronic disease?
				‚Ä¢ Early diagnosis, e. g. of diabetes, Alzheimer's,
				cancer
				‚Ä¢ Continuous monitoring and coaching, e.g. for the
				elderly, diabetes, psychiatric disease
				‚Ä¢ Discovery of new disease subtypes; design of
				new drugs; better targeted clinical trials
				33</text>
			<slideno>33</slideno>
			<text>


				Outline for today‚Äôs class
				1. Brief history of AI and ML in healthcare
				2. Why now?
				3.
				Examples of ho w ML will transform
				healthcare
				4. What is unique ab out ML in healthcare ?
				5. Overview of cl ass syllabus
				34</text>
			<slideno>34</slideno>
			<text>


				What makes healthcare different?
				‚Ä¢ Life or death d ecisions
				‚Äì Need robust alg orithms
				‚Äì Checks and ba lances built into ML deployment
				‚Äì (Also arises in other applications of AI such as autonomous
				driving)
				‚Äì Need fair and a ccountable algorithms
				‚Ä¢ Many questions are ab out unsupervised learning
				‚Äì Discovering dis ease subtypes, or answering question such
				as ‚Äúcharacterize the types of people that are highly likely to
				be readmitted to the hospital‚Äù?
				‚Ä¢ Many of the q uestions we want to answer are causal
				‚Äì Na√Øve use of s upervised machine learning is insufficient
				35</text>
			<slideno>35</slideno>
			<text>


				What makes healthcare different?
				‚Ä¢ Very little labeled d ata
				‚Äì Motivates semi -sup ervised learning algorithms
				‚Ä¢ Sometimes sma ll numbers of samples (e.g., a
				rare disease)
				‚Äì Learn as much a s possible from other data (e.g.
				healthy patients)
				‚Äì Model the pr oblem carefully
				‚Ä¢ Lots of missing d ata, varying time intervals,
				censored labels
				36</text>
			<slideno>36</slideno>
			<text>


				What makes healthcare different?
				‚Ä¢ Difficulty of de-id entifying data
				‚Äì Need for data s haring agreements and sensitivity
				‚Ä¢ Difficulty of de ploying ML
				‚Äì Commercial ele ctronic health record software is
				difficult to modify
				‚Äì Data is often i n silos; everyone recognizes need for
				interoperability, but slow progress
				‚Äì Careful testing an d iteration is needed
				37</text>
			<slideno>37</slideno>
			<text>


				Goals for the semester
				‚Ä¢ Intuition for wo rking with healthcare data
				‚Ä¢ How to set u p as machine learning problems
				‚Ä¢ Understand whi ch learning algorithms are
				likely to be useful and when
				‚Ä¢ Appreciate subtleties in safely &amp; robustly
				applying ML in healthcare
				‚Ä¢ Set the research a genda for the next decade
				38</text>
			<slideno>38</slideno>
			<text>


				6.S897/HST.956 vs 6.874
				‚Ä¢ Our class will focus on clinical data and its use
				to improve health care
				‚Ä¢ For reasons of time &amp; scope, we will not go
				deep into applications in the life sciences
				‚Äì For this, we recommend taking 6.874
				Computational Systems Biology: Deep Learning
				in the Life Sciences
				39</text>
			<slideno>39</slideno>
			<text>


				MIT OpenCourseWare
				https://ocw.mit.edu
				6.S897 / HST.956 Machine Learning for Healthcare
				Spring 2019
				For information about citing these materials or our Terms of Use, visit:
				https://ocw.mit.edu/terms
				40</text>
		</slide>
	</slides>
	<source>dummy</source>
</doc>